Generics

News

President Trump signing an Order at his desk in the Oval Office

Pharma tariffs "will hurt US consumers most of all"

If pharmaceuticals are included in President Trump's 'Liberation Day' tariffs, it is US consumers who will suffer the most, says a new report.

News

an older man's hand with a pill in his palm

FDA approves first generics of anticoagulant Xarelto

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto.

News

Hand pointing to viewer through map of China

Trump tariffs 'would strain the pharma supply chain'

Pharma organisations in the US have said that Trump's tariffs plan could drive up the cost of generics, block supply chains and worsen drug shortages.

R&D

Life Sciences Industry Report - Part 7 cover image

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

News

Novartis bid to block generic Entresto in US suffers setback

An appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic of its heart failure blockbuster Entresto.

News

three scientists in white coats in a laboratory

Accord will build £50m manufacturing plant in UK

Generic drugmaker Accord Healthcare has announced a £50 million ($65 million) investment in the UK that will include the construction of a new medicines manufacturing facility.

Pharma tariffs "will hurt US consumers most of all"

FDA approves first generics of anticoagulant Xarelto

Trump tariffs 'would strain the pharma supply chain'

Life Sciences Industry Report - Biologics and Generics

Novartis bid to block generic Entresto in US suffers setback

Accord will build £50m manufacturing plant in UK

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Generics

Editor's Picks